RICHARD ACKERMAN
CIK 1724016 · President & CEO · last filed 2021-05-25
RICHARD ACKERMAN is a President & CEO who has filed 3 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for NRXPW, was dated May 25, 2021. Across all open-market trades the lifetime net is +$450.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.3K
2
3
$450.0K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NRXPW | President & CEO | 492,065 | $0.00 | $1.3K | $0 | 1 | 2021-05-25 |
| NRX Pharmaceuticals, Inc. (BRPAW) Delisted | President and CEO | 272,500 | $7.90 | $2.15M | $450.0K | 2 | 2018-11-20 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-25 | NRXPW | Mixed | +43,630 | $0 | EDGAR |
| 2018-11-20 | NRX Pharmaceuticals, Inc. (BRPAW) Delisted | Sell (S) | −3,000,000 | $0 | EDGAR |
| 2017-12-04 | NRX Pharmaceuticals, Inc. (BRPAW) Delisted | Buy (P) | +45,000 | $450.0K | EDGAR |